Scarica l'app Stockscreener
5.54
2.01%
0.21
Precedente Chiudi:
$5.33
Aprire:
$5.36
Volume 24 ore:
8,105
Relative Volume:
0.00
Capitalizzazione di mercato:
$8.27M
Reddito:
$8.62M
Utile/perdita netta:
$-6.15M
Rapporto P/E:
-0.5023
EPS:
-11.03
Flusso di cassa netto:
$-5.32M
1 W Prestazione:
+15.93%
1M Prestazione:
+104.41%
6M Prestazione:
+13.04%
1 anno Prestazione:
-3.77%
Intervallo 1D:
$5.3279
$5.6999
Intervallo di 1 settimana:
$4.60
$5.81
Portata 52W:
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
Nome
Evoke Pharma Inc
Settore
Telefono
858-345-1494
Indirizzo
420 STEVENS AVENUE, SOLANA BEACH, CA
Confronta EVOK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
5.5415 | 8.51M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
146.51 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.41 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.505 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.18 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
302.86 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-06-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Reiterato | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Ripresa | FBR & Co. | Buy |
| 2017-03-16 | Reiterato | Rodman & Renshaw | Buy |
| 2017-01-30 | Aggiornamento | Laidlaw | Neutral → Buy |
| 2017-01-05 | Aggiornamento | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Reiterato | Rodman & Renshaw | Neutral |
| 2016-07-19 | Reiterato | FBR Capital | Outperform |
| 2016-07-19 | Downgrade | Noble Financial | Buy → Hold |
| 2016-07-18 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Iniziato | Northland Capital | Outperform |
| 2016-03-14 | Reiterato | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Ripresa | FBR Capital | Outperform |
| 2014-12-03 | Reiterato | MLV & Co | Buy |
| 2014-11-07 | Iniziato | MLV & Co | Buy |
| 2014-04-22 | Iniziato | Laidlaw | Buy |
| 2013-11-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Evoke Pharma Inc Borsa (EVOK) Ultime notizie
Using data filters to optimize entry into Evoke Pharma Inc.Stock Holding Strategy Long-Term Summary Sheet - Newser
Real time scanner hits for Evoke Pharma Inc. explainedFree Risk Controlled Picks With Real Returns - Newser
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025AI-Based Signal Detection for Active Traders - Newser
Reviewing Sol-Gel Technologies (NASDAQ:SLGL) and Evoke Pharma (NASDAQ:EVOK) - Defense World
Evoke Pharma's GIMOTI Patent Extended to 2038 Through New Patent Issuance - AInvest
Evoke Pharma's GIMOTI Patent Extended To 2038 Following New Patent Issuance - Nasdaq
Evoke Pharma announces issuance of new U.S. patent for GIMOTI - TipRanks
Evoke Pharma Secures New U.S. Patent for GIMOTI® - TipRanks
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI Wi - GuruFocus
Evoke Pharma's Extended Market Exclusivity for GIMOTI: A Strategic IP and Regulatory Triumph for Long-Term Growth - AInvest
Evoke Pharma, Inc. Announces New U.S. Patent for GIMOTI® with Extended Market Exclusivity to November 2038 - Quiver Quantitative
Evoke Pharma extends GIMOTI patent protection until 2038 By Investing.com - Investing.com Nigeria
GIMOTI Gastroparesis Treatment Secures 2-Year Patent Extension, Strengthening Market Position Through 2038 - Stock Titan
Can a trend reversal in Evoke Pharma Inc. lead to recoveryMarket Forecast Summary Over Multi-Year Period - Newser
How sentiment analysis helps forecast Evoke Pharma Inc.Stable Profit Zone and Loss Control Analysis - Newser
Applying chart zones and confluence areas to Evoke Pharma Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Evoke Pharma Inc. stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsSecure Buy Strategy Based on Risk Parameters - Newser
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
How does Evoke Pharma Inc. compare to its industry peersBuild a diversified portfolio for stability - Jammu Links News
What analysts say about Evoke Pharma Inc. stockHigh-octane gains - Jammu Links News
Is it the right time to buy Evoke Pharma Inc. stockMaximize your investment portfolio’s performance - Jammu Links News
When is Evoke Pharma Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News
Tools to monitor Evoke Pharma Inc. recovery probabilityFree Earnings Play Trade Plan With Alerts - Newser
Can momentum traders help lift Evoke Pharma Inc.Technical Confirmation System with Signal Alerts - Newser
How does Evoke Pharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - Jammu Links News
How volatile is Evoke Pharma Inc. stock compared to the marketOutperformance with explosive growth - Jammu Links News
What is the dividend policy of Evoke Pharma Inc. stockGet daily updates on market movers and shakers - Jammu Links News
What is the risk reward ratio of investing in Evoke Pharma Inc. stockGain the edge with real-time market data - Jammu Links News
Is Evoke Pharma Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
Should I hold or sell Evoke Pharma Inc. stock in 2025Free High-Return Strategy Alerts - Jammu Links News
Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Update - Defense World
What is Evoke Pharma Inc. company’s growth strategyPost Market Watchlist For Every Investor - jammulinksnews.com
Top Risks to Consider Before Buying Evoke Pharma Inc. StockAI Generated Momentum Stock Forecast Guide - Newser
Will Evoke Pharma Inc. bounce back from current supportEntry Optimization Guide with Volume Analysis - Newser
Why is Evoke Pharma Inc. stock attracting strong analyst attentionTop Growth Tips For Consistent Profits - Jammu Links News
Why Evoke Pharma Inc. stock attracts strong analyst attentionAI Volatility Forecast and Risk Monitor - Newser
Evoke Pharma (NASDAQ:EVOK) Is Using Debt Safely - simplywall.st
Why Evoke Pharma Inc. is moving todayShort-Term Trade Setup with Forecast Insight - Newser
Evoke Pharma Inc. Stock Support and Resistance Levels You Should KnowShort Term Trading Opportunity Watch Sees Shift - metal.it
Quant Models Detect Momentum Reversal in Evoke Pharma Inc.Risk Managed Intraday Trade Alerts Increase in Volume - metal.it
How did EVOK's revenue surge in Q4 2024 despite rising expenses? - AInvest
Evoke Pharma Inc Azioni (EVOK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):